Literature DB >> 2573910

Presynaptic modulation of transmitter release by nicotinic receptors.

S Wonnacott, J Irons, C Rapier, B Thorne, G G Lunt.   

Abstract

Mesh：

Substances：

Year:  1989        PMID： 2573910     DOI： 10.1016/s0079-6123(08)62475-9

Source DB:  PubMed          Journal:  Prog Brain Res        ISSN： 0079-6123            Impact factor:   2.453


× No keyword cloud information.
  34 in total

1.  Functional characterization of intrinsic cholinergic interneurons in the cortex.

Authors:  Jakob von Engelhardt; Marina Eliava; Axel H Meyer; Andrei Rozov; Hannah Monyer
Journal:  J Neurosci       Date:  2007-05-23       Impact factor: 6.167

Review 2.  Modulators in concert for cognition: modulator interactions in the prefrontal cortex.

Authors:  Lisa A Briand; Howard Gritton; William M Howe; Damon A Young; Martin Sarter
Journal:  Prog Neurobiol       Date:  2007-06-30       Impact factor: 11.685

3.  Enhanced dendritic action potential backpropagation in parvalbumin-positive basket cells during sharp wave activity.

Authors:  Balázs Chiovini; Gergely F Turi; Gergely Katona; Attila Kaszás; Ferenc Erdélyi; Gábor Szabó; Hannah Monyer; Attila Csákányi; E Sylvester Vizi; Balázs Rózsa
Journal:  Neurochem Res       Date:  2010-11-03       Impact factor: 3.996

4.  Chronic memantine decreases nicotine self-administration in rats.

Authors:  Edward D Levin; Corinne Wells; Leah Yao; Wendi Guo; Anica Nangia; Sarah Howard; Erica Pippen; Andrew B Hawkey; Jed E Rose; Amir H Rezvani
Journal:  Eur J Pharmacol       Date:  2019-08-14       Impact factor: 4.432

Review 5.  Desensitization of central cholinergic mechanisms and neuroadaptation to nicotine.

Authors:  E L Ochoa; L Li; M G McNamee
Journal:  Mol Neurobiol       Date:  1990 Fall-Winter       Impact factor: 5.590

Review 6.  Nicotinic interactions with antipsychotic drugs, models of schizophrenia and impacts on cognitive function.

Authors:  Edward D Levin; Amir H Rezvani
Journal:  Biochem Pharmacol       Date:  2007-07-20       Impact factor: 5.858

7.  Reversal of visual attentional dysfunction following lesions of the cholinergic basal forebrain by physostigmine and nicotine but not by the 5-HT3 receptor antagonist, ondansetron.

Authors:  J L Muir; B J Everitt; T W Robbins
Journal:  Psychopharmacology (Berl)       Date:  1995-03       Impact factor: 4.530

8.  Ketanserin, a 5-HT2 receptor antagonist, decreases nicotine self-administration in rats.

Authors:  Edward D Levin; Susan Slade; Michael Johnson; Ann Petro; Kofi Horton; Paul Williams; Amir H Rezvani; Jed E Rose
Journal:  Eur J Pharmacol       Date:  2008-10-17       Impact factor: 4.432

9.  The endogenous cannabinoid system modulates nicotine reward and dependence.

Authors:  Lisa L Merritt; B R Martin; C Walters; A H Lichtman; M Imad Damaj
Journal:  J Pharmacol Exp Ther       Date:  2008-05-01       Impact factor: 4.030

10.  Nerve terminal currents induced by autoreception of acetylcholine release.

Authors:  W M Fu; H C Liou; Y H Chen
Journal:  J Neurosci       Date:  1998-12-01       Impact factor: 6.167
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.